Logo-ajdr
Submitted: 05 Feb 2024
Revised: 12 May 2024
Accepted: 18 May 2024
First published online: 29 Jun 2024
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - FireFox Plugin)

Abstract View: 454
PDF Download: 285
Full Text View: 6
Avicenna J Dent Res. 16(2):108-116. doi: 10.34172/ajdr.1787

Review Article

Collision Lesions in Head and Neck Area: A Retrospective Study of 97 Reported Cases

Soussan Irani 1, 2, * ORCID logo, Alfred Lam 3, 4 ORCID logo

Author information:
1Oral Pathology Department, Dental Faculty, Dental Research Center, Hamadan University of Medical Sciences, Hamadan, Iran
2Adjunct Senior Lecturer in the School of Medicine and Dentistry, Griffith University, Gold Coast, Q4222, Australia
3School of Medicine and Dentistry, Griffith University, Gold Coast, Q4222, Australia
4Faculty of Medicine, The University of Queensland, Herston, Q4006, Australia

*Corresponding author: Soussan Irani, Email: sousanirani@gmail.com and Irani@umsha.ac.ir

Abstract

Background: Collision (hybrid) lesions consist of two or more distinct histologic types occurring separately but within the same area. This review focuses on discussing all related and available case reports of hybrid lesions in the head and neck area.

Methods: The literature was searched using several databases, including Scopus, Web of Science, PubMed, and Google Scholar. Papers published from 1990 to 2022 with full text available were considered for inclusion in the study. For a more comprehensive understanding, all lesions were categorized into cutaneous, jaw, and salivary gland groups and lesions in miscellaneous tissues.

Results: In general, 97 reported collision lesions developed in the head and neck region. Among them, 31 (32%) and 34 (35%) cases were cutaneous hybrid lesions and in the jaws, respectively. In addition, 27 (27.8%) and 5 (5.1%) cases were in salivary glands and miscellaneous tissues, respectively.

Conclusion: While the presence of true hybrid tumors is well-established, some reported cases have prompted researchers to categorize them as biphasic differentiations. The rarity of these cases contributes to limited knowledge regarding their clinical behavior, prognosis, and optimal treatment. It is crucial to emphasize the characteristic and potentially perplexing histological appearances.

Keywords: Hybrid, Jaw, Odontogenic, Salivary glands, Skin

Copyright and License Information

© 2024 The Author(s); Published by Hamadan University of Medical Sciences.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium provided the original work is properly cited.

Please cite this article as follows: Irani S, Lam A. Collision lesions in head and neck area: a retrospective study of 97 reported cases. Avicenna J Dent Res. 2024; 16(2):108-116. doi:10.34172/ajdr.1787


Background

Collision (hybrid) lesions comprise two or more distinct histologic types separately occurring but within a similar area. While these lesions occur only occasionally, their occurrences have been well recognized. They may manifest as either benign conditions or malignant tumors (1). Biphasic differentiated lesions present as mixtures of two or more cellular patterns corresponding to lesion classification (2). There is a limited body of research about the epidemiology of collision lesions. However, a retrospective observational study of 77 proven hybrid skin lesions, collected from nine countries, revealed collision lesions on the head and neck area (24.7%), the trunk (48.1%), the lower extremities (11.7%), and the upper extremities (5.2%) (3). A previous systematic review reported only 203 cases of reported hybrid odontogenic lesions in the literature (4). In addition, it has been shown that hybrid salivary gland neoplasms comprise 0.1% of all salivary gland tumors (5).

The pathogenesis of collision lesions remains a controversial issue, and three theories may explain the co-existence of two or more pathological entities (tumors/lesions) simultaneously. Firstly, they may result from the proliferation of two different cell lines. Secondly, they might share a common origin in a totipotent cell, which differentiates into two different cell lines. The third theory involves the sarcomatous conversion of an epithelial tumor (6). Regarding collision tumors, it has been suggested that pathogenic mechanisms such as the “random collision effect”, “field cancerization”, and “tumor-to-tumor carcinogenesis” are involved in this phenomenon (7). Additionally, composite tumors have been explained in the literature. These tumors develop due to a common driver mutation with different histological features from a common tumor source (8). Both composite and collision tumors have distinct morphological and histological features coexisting within the same organ. However, the intermingling of cells detected in composite lesions cannot be observed in collision lesions (8).

The simultaneous occurrence of lesions in different tissues has been documented, emphasizing the importance of reviewing reported cases of collision lesions, especially since the treatment protocol for each entity varies (9). This review discusses all related and available case reports of hybrid lesions in the head and neck area.


Materials and Methods

The literature was searched using the Scopus database, Web of Science, PubMed, and Google Scholar. Papers published from 1990 to 2022 with full texts were considered for inclusion in the study. For a more comprehensive understanding, all lesions were classified into salivary gland lesions, jaw lesions, cutaneous lesions, and lesions in miscellaneous tissues.


Results

In general, 97 reported collision lesions developed in the head and neck regions. Among the cases, 31 (32%) were cutaneous hybrid lesions. The most common cutaneous lesion combined with other lesions was basal cell carcinoma (BCC), with 17 cases (17.5%), followed by malignant melanoma (n = 13, 13.4%). Table 1 summarizes all documented cutaneous collision lesions.


Table 1. Collision Cutaneous Lesions in the Head and Neck Area
First Lesion Second Lesion Site Gender Age Range (y) Duration Survival Status After Diagnosis Until the Report of Case Reference
BCC Atypical fibroxanthoma Nose F 85 3 years Alive (10)
BCC Lentigo maligna Nose M 78 2 months Alive (11)
BCC Lentigo maligna Nose F 82 No data Alive (12)
BCC Seborrheic keratosis Nose F 62 No data Alive (13)
BCC Seborrheic keratosis Occipital F 78 A few months Alive (14)
BCC Seborrheic keratosis Auricle F 89 No data Alive (15)
BCC Seborrheic keratosis Cheek M 82 Several years Alive (16)
BCC Seborrheic keratosis Temple M 68 12 years Alive (17)
BCC Melanocytic nevus Neck M 63 A few months Alive (17)
BCC Superficial spreading Melanoma Nose M 76 No data Alive (18)
BCC Keratoacanthoma Cheek M 46 6 weeks Alive (19)
BCC Melanoma Neck F 68 Several years Alive (20)
BCC Melanoma Temple M 79 Several months Died 3 months later (21)
BCC Melanoma Scalp M 78 No data Alive (22)
BCC Melanoma Canthus M 91 No data Alive (23)
BCC Sclerosing blue nevus Scalp F 67 A few months Alive (24)
BCC Signet-ring SCC Eyelid F 93 6 months Alive (25)
Atypical fibroxanthoma Melanoma Scalp M 76 3 months Alive (26)
Chondroid syringomas Intradermal melanocytic nevus Nose F 70 6 months Alive (27)
desmoplastic trichoepithelioma Melanocytic nevus Cheek F 27 2 years Alive (28)
Invasive SCC Invasive melanoma Scalp M 98 1 year Alive (1)
Acantholytic SCC Atypical fibroxanthoma Cheek M 60 Several years Alive (29)
SCC Melanoma Cheek F 84 No data Alive (30)
SCC Melanoma Lower lip M 46 No data Alive (31)
Trichoblastoma BE/F neoplasm Cheek M 69 No data Alive (32)
Trichoblastoma Inverted follicular keratosis Chin M 40 No data Alive (32)
Trichoblastoma BE/F neoplasm Forehead M 49 No data Alive (32)
Trichoblastoma BE/F neoplasm Occipital M 27 No data Alive (32)
Trichoblastoma Seborrheic keratosis Scalp F 28 2 months Alive (33)
BSCC Melanoma Frontal M 60 25 years Alive (34)
Merkel cell carcinoma Lentigo maligna Melanoma Cheek M 79 No data Alive (35)

Note. BCC: Basal cell carcinoma; SCC: Squamous cell carcinoma; BE/F: Benign epidermal/follicular; BSCC: Basosquamous cell carcinoma.

There were 34 cases (35%) of hybrid lesions in the jaws. The most common lesions in the jaws were odontogenic lesions (n = 33, 34%). An adenomatoid odontogenic tumor (AOT) was the most common odontogenic lesion combined with other lesions (n = 13, 13.4%), followed by central odontogenic fibroma (COF; n = 10, 10.3%). Considering non-odontogenic lesions, central giant cell granuloma (CGCG) was the most common hybrid lesion in the jaws (n = 10, 10.3%). CGCG was combined with COF in 8 cases and odontogenic keratocyst (OKC) in 2 cases. The mandible was the most frequently affected site, with 24 cases (24.7%). Table 2 provides information about hybrid lesions in the jaws.


Table 2. Collision Lesions in Jaws
First Lesion Second Lesion Site Gender Age Range (y) Duration Survival Status After Diagnosis Until the Report of Case Reference
CCOT Ameloblastoma Mandible M 17 1 month Alive (36)
CCOT AFO Mandible F 4 No data Alive (37)
CCOT AOT and ameloblastoma Mandible F 64 16 months Alive (38)
CCOT AOT Maxilla F 2 No data Alive (39)
CEOT AOT Mandible F 17 No data Alive (40)
CEOT AOT Maxilla F 16 No data Alive (41)
CEOT AOT Maxilla F 23 No data Alive (42)
COC AFO and AOT Mandible M 7 No data Alive (43)
COC AF Maxilla M 13 No data Alive (44)
COC AF Mandible M 22 3 weeks Alive (44)
COC AF Mandible F 6 No data Alive (44)
COC AF Mandible F 14 10 days Alive (45)
COC AF Mandible M 10 No data Alive (46)
COC AF Maxilla F 22 3 months Alive (47)
OKC Ameloblastoma Mandible F 17 3 months Alive (46)
OKC CGCG Mandible M 29 No data Alive (48)
OKC CGCG Mandible M 10 3 months Alive (49)
BPNST Peripheral osteoma Palate M 61 6 months Alive (50)
AOT Ameloblastoma Mandible F 31 No data Alive (51)
AOT UA Mandible F 31 No data Alive (9)
AOT FCOD Maxilla F 24 9 months Alive (52)
AOT FOL Maxilla F 22 1 month Alive (53)
AOT FOL Maxilla F 34 No data Alive (54)
AOT COF Maxilla F 23 No data Alive (54)
AOT COF Mandible F 30 4 months Alive (55)
COF CGCG Mandible F 57 No data Alive (56)
COF CGCG Mandible F 15 No data Alive (57)
COF CGCG Mandible M 18 No data Alive (57)
COF CGCG Mandible M 25 No data Alive (57)
COF CGCG Mandible M 50 No data Alive (57)
COF CGCG Mandible M 59 No data Alive (57)
COF CGCG Mandible M 73 No data Alive (57)
COF CGCG Mandible M 19 No data Alive (57)
Ameloblastoma Hemangioma Mandible M 42 6 months Alive (58)

Note. CCOT: Calcifying cystic odontogenic tumor; COC: Calcifying odontogenic cyst; CEOT: Calcifying epithelial odontogenic tumor; OKC: Odontogenic keratocyst; BPNST: Benign peripheral nerve sheath tumor; AOT: Adenomatoid odontogenic tumor; COF: Central odontogenic fibroma; AFO: Ameloblastic fibro-odontoma; AF: Ameloblastic fibroma; CGCG: Central giant cell granuloma; UA: Unicystic ameloblastoma; FCOD: Focal cemento-osseous dysplasia; FOL: Fibro-osseous lesion; COF: Cemento-ossifying fibroma.

There were 27 documented cases (27.8%) of salivary gland collision lesions. The most common combined salivary gland lesion was adenoid cystic carcinoma (AdCC) with 13 cases (13.4%), followed by salivary duct carcinoma (SDC) with 11 cases (11.3%). The parotid gland was the most affected salivary gland, with 19 cases (19.5%). Table 3 lists all reported hybrid salivary gland lesions. In addition, there were 5 cases (5.1%) of collision lesions in miscellaneous tissues (Table 4).


Table 3. Collision salivary gland lesions
First Lesion Second Lesion Site Gender Age
Range (Years)
Duration Survival Status After Diagnosis Until the Report of Case Reference
Warthin tumor Small lymphocytic lymphoma Parotid M 60 3-4 years Alive (59)
Warthin tumor Sebaceous adenoma Parotid M 60 A few months Alive (5)
AdCC Basal cell adenoma Parotid M 62 A few months Alive (5)
AdCC MEC Palate F 49 No data Alive (60)
AdCC EMC Palate M 71 No data Alive (60)
AdCC MEC Parotid M 53 No data Alive (61)
AdCC EMC Parotid M 71 No data Alive (61)
AdCC EMC Palate F 66 No data Alive (5)
AdCC EMC Maxillary sinus F 26 3 months Died after 8 years (62)
AdCC SDC Palate M 51 No data Alive (61)
AdCC SDC Parotid M 40 No data Alive (6)
AdCC Mucous retention cyst Parotid F 14 No data Alive (63)
AdCC SDC Sublingual gland F 59 No data Alive (64)
AdCC SDC Submandibular F 81 No data Died (6)
EMC SDC Parotid M 28 Alive Alive (61)
EMC AdCC and BCAC Parotid M 51 10 years Alive (65)
EMC SDC Parotid M 74 No data Alive (66)
EMC BCAC Parotid F 74 No data Alive (6)
EMC BCAC Parotid M 56 No data Alive (6)
EMC Keratinizing SCC Parotid F 73 No data Alive (6)
Keratinizing SCC SDC Parotid M 66 No data Alive (6)
Keratinizing SCC SDC Lacrimal gland F 64 No data Alive (6)
ACC SDC Parotid M 53 A few weeks No data (5)
MC SDC Parotid M 65 No data Alive (6)
ACC SDC Parotid M 42 No data Died (6)
Basal cell adenoma Canalicular adenoma Parotid M 70 15-20 years Alive (5)
Neurofibroma Schwannoma Intraparotid facial nerve F 29 2 years Alive (67)

Note. AdCC: Adenoid cystic carcinoma; EMC: Epithelial-myoepithelial carcinoma; ACC: Acinic cell carcinoma; SDC: Salivary duct carcinoma; BCAC: Basal cell adenocarcinoma; MC: Myoepithelial carcinoma.


Table 4. Miscellaneous collision lesions in different sites
First Lesion Second Lesion Site Gender Age
Range (Years)
Duration Survival Status After Diagnosis Until the Report of Case Reference
OSCC Papillary thyroid carcinoma Cervical lymph Node M 47 2 months Alive (68)
SCC Small cell carcinoma Hypopharynx M 74 3 months Alive (69)
SCC and adenocarcinoma SNEC Maxillary sinus F 52 1 month Alive (70)
SCC Osteosarcoma Maxillary sinus M 24 6 months Alive (71)
ITAC PDNC ethmoid No data 79 No data 26 months (72)

Note. SNEC: Small cell neuroendocrine carcinoma; ITAC: Sinonasal intestinal-type adenocarcinoma; PDNC: Poorly differentiated neuroendocrine carcinoma.


Discussion

A collision lesion refers to the simultaneous presence of two distinct primary lesions in a single anatomical site without significant histological admixture at the interface (59). This occurrence may be coincidental, or there could be a related pathogenesis (59). It is believed that two independently arising primary lesions converge in the same location, or that the development of one lesion modifies the surrounding microenvironment, allowing a second lesion to emerge in the same area (73).

The coexistence of BCC, the most common skin cancer, with other skin lesions such as melanocytic nevus, seborrheic keratosis, and malignant melanoma has been previously reported (1,74). In the current review, 54.8% of cutaneous hybrid lesions were BCCs. However, a prior paper detected BCCs in 34.3% of all skin hybrid cases in head and neck areas (3). The hypothesis suggests that the presence of one tumor may induce epithelial or stromal changes, facilitating the development of a second lesion. Skin damage due to chronic exposure to sunlight is considered the primary etiologic factor for BCC, malignant melanoma, and some other cutaneous lesions (20). Some studies have demonstrated that BCCs originate from the basal layer of the epidermis and the hair follicle outer root sheath. Consequently, normal melanocytes are probably entrapped as the tumor grows (12,75). Another study has revealed that BCC contains HMB45-positive melanocytes. As a result, the abnormal stimulation of these melanocytes may lead to the development of malignant melanoma within BCC (20).

In total, 25 cases (25.7%) of odontogenic lesions combined with other lesions were noted in the current review. The mechanism of the association of two different odontogenic lesions is unclear, but it is believed that the second lesion is a secondary phenomenon of a pre-existing tumor. A growing body of research shows that the hybrid odontogenic lesion is the result of the pluripotent characteristics of the odontogenic epithelium. It means that both lesions develop from a common source (46,76,77). Different sources for the odontogenic epithelium have been demonstrated. The rests of dental lamina (in the alveolar bone), the epithelial cell rests of Malassez (Hertwig’s root sheath remnants) in the periodontal ligament, the rests of the enamel organ and reduced enamel epithelium (deep in the body of jaw bones), the rests of Serres (in the gingiva), and the peri-coronal follicular tissue are considered the main sources of odontogenic epithelial stem cells (78-81). A previously published study revealed that the embryonic residues of the odontogenic epithelium within the jaws are capable of proliferating and developing different odontogenic lesions (79). Notably, the majority of odontogenic lesions are associated with an impacted tooth (36). In a recent systematic review, 24.1% of cases were AOT combined with a calcifying epithelial odontogenic tumor (CEOT) or dentigerous cysts (12.8% vs. 11.3%) (4). Our findings demonstrated AOT in 39.3% of cases combined with different odontogenic and non-odontogenic lesions (Table 2). The pathogenic mechanism is unclear; however, it has been suggested that it is a collision of two separate lesions or a transformation of one lesion into another. For example, the solid portion of CCOT and COC may have some characteristics of odontogenic tumors, such as ameloblastoma, AF, and AFO. In addition, it is believed that the proliferation of odontogenic epithelium in COC might induce the adjacent mesenchymal tissue to develop the characteristics of other odontogenic tumors (47,80). It has been shown that AOT arises from epithelial remnants such as dental lamina, Serres pearls, or Hertwig’s epithelial root sheet and the enamel organ (52). It has been demonstrated that some odontogenic cysts occur in association with odontogenic lesions, including AOT. For instance, an association of AOT with dentigerous cysts has been reported (82). Apparently, both AOT and the dentigerous cyst are associated with an impacted tooth and are both common in younger patients and in the anterior maxilla (82). Histologically, AOT is partly cystic in some cases; therefore, it is unclear whether the lining of the associated cyst is a true dentigerous cyst or is only a secondary cystic change within an AOT (83). Even the radiographic findings in AOT are frequently similar to those of other odontogenic lesions, such as the dentigerous cyst and COC (42). A combination of CCOT or COC with other odontogenic lesions such as ameloblastoma, AF, and AFO had been reported as well (9). CEOT is also associated with AOT (84). The mechanism is unclear, but some authors suggest that CCOT may contribute to the development of other types of odontogenic tumors (36). Nevertheless, some other authors believe that the second lesion is a secondary phenomenon of a pre-existing tumor (85,86). Interestingly, CEOT is a benign, slow-growing odontogenic tumor (87), but AOT is considered a hamartoma with a limited growth rate (80). It is hypothesized that neoplastic and hamartomatous lesions can occur at any stage of odontogenesis (82).

Several published reports have documented the coexistence of OKC with other lesions, including CGCG and ameloblastoma (46,48,49). Numerous studies have revealed the association of CGCG with other lesions, such as OKC, COF, and the aneurysmal bone cyst (57,88,89). Three mechanisms have been suggested to explain the coexistence of an odontogenic tumor/lesion and CGCG. Firstly, this combination may result from a “collision tumor/lesion”, representing the synchronous occurrence of an odontogenic lesion and CGCG. Secondly, the giant cell reaction induces odontogenic epithelium and ectomesenchyme, typically found in the tooth-bearing areas of the jaws, through the secretion of growth factors (56). The third theory proposes that an odontogenic lesion, such as COF, is a primary lesion inducing a reactive CGCG in the presence of a stimulus, such as trauma (90).

Collision (hybrid) tumors of the salivary glands are very rare and are composed of two or more different entities in a single neoplasm. Salivary gland tumors are made up of biologically and histologically diverse lesions (91,92). These types of tumors originate in different regions but coalesce in a particular area. Histologically, there is a transitional zone between two entities. Salivary duct stem cells or reserve cells are suggested as the sources of these types of lesions (60,93). The parotid gland is the most common site for salivary gland tumors (91,94). In the present review, parotid tumors were the most common type of salivary gland tumors, and AdCC was the most common salivary gland tumor combined with other lesions (n = 13, 13.4%). In a previous study, SDC was the most common salivary gland tumor combined with other tumors (66).

Overall, a precise diagnosis to distinguish between two different tumors and between benign and malignant lesions in the same area plays an important role in appropriate patient treatment. The treatment plan and prognosis are different and are based on the accompanying tumor. It is also believed that the predominant component determines the biological behavior of the lesion and treatment plan (60). For example, melanomas arising within less aggressive lesions behave less aggressively (12). Furthermore, AOT is typically managed through surgical excision. However, a more extensive radical excision is required when it is associated with other lesions, such as ameloblastoma. Long-term follow-up is crucial in such cases, as ameloblastoma has the potential to metastasize to cervical lymph nodes and distant sites (9).Interestingly, the presence of giant cell granuloma-like areas in COF-like lesions increases the risk of recurrence following curettage (89). Additionally, the prognosis of hybrid cases of COF with a GCG-like component seems to be a locally aggressive course; however, reactive GCG-like lesions and a typical COF have better biological behavior and prognosis (52).


Conclusion

While the presence of true hybrid tumors is well-established, some reported cases have prompted the researchers to categorize them as biphasic differentiations. The rarity of these cases contributes to limited knowledge regarding their clinical behavior, prognosis, and optimal treatment. It is crucial to emphasize the characteristic and potentially perplexing histological appearances. Molecular analysis proves beneficial in many instances. Hence, a meticulous examination of surgical and histologic specimens is imperative for determining appropriate treatment plans and predicting prognosis.


Authors’ Contribution

Data curation: Soussan Irani, Alfred K. Lam.

Formal analysis: Soussan Irani.

Investigation: Soussan Irani.

Methodology: Alfred K. Lam, Soussan Irani.

Project administration: Soussan Irani, Alfred K. Lam.

Supervision: Soussan Irani.

Validation: Soussan Irani.

Writing–original draft: Soussan Irani.

Writing–review & editing: Soussan Irani, Alfred K. Lam.


Competing Interests

The authors declare that they have no conflict of interests.


Ethical Approval

Not applicable.


References

  1. Mopuri N, Laitung JK, Cardozo C. Collision tumour of squamous cell carcinoma and invasive malignant melanoma of scalp - a case report. J Plast Reconstr Aesthet Surg 2009; 62(5):e104-5. doi: 10.1016/j.bjps.2008.07.033 [Crossref] [ Google Scholar]
  2. Čabrijan L, Cvečić A, Lipozenčić J, Goldust M, Simonić E, Batinac T. Collision lesions: genuine collision (conflict) or not?. Acta Dermatovenerol Croat 2022; 30(2):76-81. [ Google Scholar]
  3. Blum A, Siggs G, Marghoob AA, Kreusch J, Cabo H, Campos-do-Carmo G. Collision skin lesions-results of a multicenter study of the International Dermoscopy Society (IDS). Dermatol Pract Concept 2017; 7(4):51-62. doi: 10.5826/dpc.0704a12 [Crossref] [ Google Scholar]
  4. Pontes FS, Mosqueda-Taylor A, de Souza LL, de Paula LP, Batista LA, Rodrigues-Fernandes CI. Hybrid odontogenic lesions: a systematic review of 203 cases reported in the literature. J Oral Pathol Med 2022; 51(1):5-12. doi: 10.1111/jop.13238 [Crossref] [ Google Scholar]
  5. Seifert G, Donath K. Hybrid tumours of salivary glands Definition and classification of five rare cases. Eur J Cancer B Oral Oncol 1996; 32B(4):251-9. doi: 10.1016/0964-1955(95)00059-3 [Crossref] [ Google Scholar]
  6. Nagao T, Sugano I, Ishida Y, Asoh A, Munakata S, Yamazaki K. Hybrid carcinomas of the salivary glands: report of nine cases with a clinicopathologic, immunohistochemical, and p53 gene alteration analysis. Mod Pathol 2002; 15(7):724-33. doi: 10.1097/01.mp.0000018977.18942.fd [Crossref] [ Google Scholar]
  7. Oh KS, Bahmad HF, Febres-Aldana CA, Safdie FM, Sriganeshan V. Collision tumors of the lung: a case report of urothelial carcinoma metastasizing to renal cell carcinoma with heterotopic ossification. Respir Med Case Rep 2020; 31:101297. doi: 10.1016/j.rmcr.2020.101297 [Crossref] [ Google Scholar]
  8. Sung CT, Shetty A, Menias CO, Houshyar R, Chatterjee S, Lee TK. Collision and composite tumors; radiologic and pathologic correlation. Abdom Radiol (NY) 2017; 42(12):2909-26. doi: 10.1007/s00261-017-1200-x [Crossref] [ Google Scholar]
  9. Sathyanarayana VK, Srigiri H, Cheemalavagupalli M, Vankadara S, Malika G. A rare case of adenomatoid odontogenic tumour with unicystic ameloblastoma. J Clin Diagn Res 2017; 11(2):ZJ05-6. doi: 10.7860/jcdr/2017/23623.9412 [Crossref] [ Google Scholar]
  10. Alves R, Ocaña J, Vale E, Correia S, Viana I, Bordalo O. Basal cell carcinoma and atypical fibroxanthoma: an unusual collision tumor. J Am Acad Dermatol 2010; 63(3):e74-6. doi: 10.1016/j.jaad.2009.11.685 [Crossref] [ Google Scholar]
  11. Taibjee SM, Gee BC, Sanders DS, Smith A, Carr RA. Lentigo maligna involving the tumour nests and stroma of a nodular basal cell carcinoma. Br J Dermatol 2007; 157(1):184-8. doi: 10.1111/j.1365-2133.2007.07904.x [Crossref] [ Google Scholar]
  12. Belisle A, Gautier MS, Ghozali F, Plantier F, Wechsler J. A collision tumor involving Basal cell carcinoma and lentigo maligna melanoma. Am J Dermatopathol 2005; 27(4):319-21. doi: 10.1097/01.dad.0000164603.49026.6a [Crossref] [ Google Scholar]
  13. Ferrara G, Zalaudek I, Cabo H, Soyer HP, Argenziano G. Collision of basal cell carcinoma with seborrhoeic keratosis: a dermoscopic aid to histopathology?. Clin Exp Dermatol 2005; 30(5):586-7. doi: 10.1111/j.1365-2230.2005.01810.x [Crossref] [ Google Scholar]
  14. Bedir R, Yurdakul C, Güçer H, Sehitoglu I. Basal cell carcinoma arising within seborrheic keratosis. J Clin Diagn Res 2014; 8(7):YD06-7. doi: 10.7860/jcdr/2014/8665.4604 [Crossref] [ Google Scholar]
  15. Ishida M, Ohsato N, Okabe H. Basal cell carcinoma arising within a seborrheic keratosis with respect to immunohistochemical characteristics. Oncol Lett 2011; 2(4):625-7. doi: 10.3892/ol.2011.303 [Crossref] [ Google Scholar]
  16. Shibao K, Okiyama N, Tanaka R, Maruyama H, Fujisawa Y, Fujimoto M. Nodulocystic basal cell carcinoma arising directly from a seborrheic keratosis: a rare case report. Indian J Dermatol 2016; 61(4):443-5. doi: 10.4103/0019-5154.185720 [Crossref] [ Google Scholar]
  17. Zaballos P, Llambrich A, Puig S, Malvehy J. Dermoscopy is useful for the recognition of benign-malignant compound tumours. Br J Dermatol 2005; 153(3):653-6. doi: 10.1111/j.1365-2133.2005.06717.x [Crossref] [ Google Scholar]
  18. King R, Lyons J, Meyers AL, Googe PB, Page RN, Gupta VK. Primary invasive melanoma and basal cell carcinoma (collision tumor) with blue nevus-like cutaneous metastases. J Cutan Pathol 2007; 34(8):629-33. doi: 10.1111/j.1600-0560.2006.00677.x [Crossref] [ Google Scholar]
  19. Kim TH, Lee JH, Roh MR. A case of keratoacanthoma associated with Basal cell carcinoma. Ann Dermatol 2015; 27(2):237-8. doi: 10.5021/ad.2015.27.2.237 [Crossref] [ Google Scholar]
  20. Papa G, Grandi G, Pascone M. Collision tumor of malignant skin cancers: a case of melanoma in basal cell carcinoma. Pathol Res Pract 2006; 202(9):691-4. doi: 10.1016/j.prp.2006.01.016 [Crossref] [ Google Scholar]
  21. Sharma SJ, Kreisel M, Holler C, Kroll T, Gamerdinger U, Gattenloehner S. Compound lesion of a basal cell carcinoma and a malignant melanoma: is there a common genetic origin?. Eur Arch Otorhinolaryngol 2015; 272(2):505-9. doi: 10.1007/s00405-014-3318-6 [Crossref] [ Google Scholar]
  22. Hirakawa E, Miki H, Kobayashi S, Nomura Y, Ohmori M. Collision tumor of cutaneous malignant melanoma and basal cell carcinoma. Pathol Res Pract 1998; 194(9):649-53. doi: 10.1016/s0344-0338(98)80102-7 [Crossref] [ Google Scholar]
  23. Litak J, Behroozan D, Binder S. Co-existing basal cell carcinoma and blue nevus in an African-American woman. J Cutan Pathol 2009; 36(10):1114-6. doi: 10.1111/j.1600-0560.2008.01245.x [Crossref] [ Google Scholar]
  24. Aghighi M, Chercover D, Rahvar M. Collision cutaneous neoplasms consisting of melanoma and basal cell carcinoma. Dermatol Pract Concept 2021; 11(3):e2021037. doi: 10.5826/dpc.1103a37 [Crossref] [ Google Scholar]
  25. Proia AD, Selim MA, Reutter JC, Michon JJ. Basal cell-signet-ring squamous cell carcinoma of the eyelid. Arch Pathol Lab Med 2006; 130(3):393-6. doi: 10.5858/2006-130-393-bcscco [Crossref] [ Google Scholar]
  26. Wilsher MJ. Collision tumour: atypical fibroxanthoma and invasive melanoma. Pathology 2009; 41(7):699-701. doi: 10.3109/00313020903305746 [Crossref] [ Google Scholar]
  27. Lee HC, Tan KW, Chia MW, Sim CS. An unusual collision tumour masquerading as a basal cell carcinoma on the nose. Singapore Med J 2012; 53(12):e267-8. [ Google Scholar]
  28. Oliveira A, Arzberger E, Zalaudek I, Hofmann-Wellenhof R. Desmoplastic trichoepithelioma and melanocytic nevus: dermoscopic and reflectance confocal microscopy presentation of a rare collision tumor. J Am Acad Dermatol 2015; 72(1 Suppl):S13-5. doi: 10.1016/j.jaad.2014.03.047 [Crossref] [ Google Scholar]
  29. Hyatt AM, Mutasim DF, Spicknall KE. Collision of atypical fibroxanthoma and acantholytic squamous cell carcinoma in situ. Am J Dermatopathol 2012; 34(5):563-4. doi: 10.1097/DAD.0b013e31822e63c8 [Crossref] [ Google Scholar]
  30. Ahlgrimm-Siess V, Hofmann-Wellenhof R, Zalaudek I, Cerroni L, Kerl H. Collision of malignant melanoma (lentigo maligna type) with squamous cell carcinoma in solar-damaged skin of the face. Dermatol Surg 2007; 33(1):122-4. doi: 10.1111/j.1524-4725.2007.33023.x [Crossref] [ Google Scholar]
  31. Falanga V, Chartier M, Butmarc J, Tibbetts L. Collision of desmoplastic-neurotropic melanoma and squamous cell carcinoma on the lip. J Cutan Pathol 2008; 35(5):473-6. doi: 10.1111/j.1600-0560.2007.00829.x [Crossref] [ Google Scholar]
  32. Battistella M, Peltre B, Cribier B. Composite tumors associating trichoblastoma and benign epidermal/follicular neoplasm: another proof of the follicular nature of inverted follicular keratosis. J Cutan Pathol 2010; 37(10):1057-63. doi: 10.1111/j.1600-0560.2009.01341.x [Crossref] [ Google Scholar]
  33. Loh SH, Lew BL, Sim WY. Composite tumor associating trichoblastoma and seborrheic keratosis. Ann Dermatol 2015; 27(5):601-4. doi: 10.5021/ad.2015.27.5.601 [Crossref] [ Google Scholar]
  34. Medeiros PM, de Magalhães Alves NR, da Silva CC, de Faria PC, Barcaui CB, Piñeiro-Maceira J. Collision of malignant neoplasms of the skin: basosquamous cell carcinoma associated with melanoma. An Bras Dermatol 2015; 90(3 Suppl 1):39-42. doi: 10.1590/abd1806-4841.20153845 [Crossref] [ Google Scholar]
  35. Forman SB, Vidmar DA, Ferringer TC. Collision tumor composed of Merkel cell carcinoma and lentigo maligna melanoma. J Cutan Pathol 2008; 35(2):203-6. doi: 10.1111/j.1600-0560.2007.00773.x [Crossref] [ Google Scholar]
  36. Chaubey SS, Mishra SS, Degwekar SS, Chaubey S. A rare presentation of hybrid odontogenic tumor involving calcifying cystic odontogenic tumor and plexiform ameloblastoma. Contemp Clin Dent 2013; 4(3):406-8. doi: 10.4103/0976-237x.118369 [Crossref] [ Google Scholar]
  37. Lee J, Song YG, Moon SY, Choi B, Kim BC, Yoon JH. Calcifying cystic odontogenic tumor associated with ameloblastic fibro-odontoma of the anterior mandible. J Craniofac Surg 2014; 25(3):e259-60. doi: 10.1097/scs.0000000000000563 [Crossref] [ Google Scholar]
  38. Zhang W, Chen Y, Geng N, Bao D, Yang M. A case report of a hybrid odontogenic tumour: ameloblastoma and adenomatoid odontogenic tumour in calcifying cystic odontogenic tumour. Oral Oncol Extra 2006; 42(9):287-90. doi: 10.1016/j.ooe.2006.07.003 [Crossref] [ Google Scholar]
  39. Soares EC, Costa FW, Neto IC, Bezerra TP, do Socorro Vidal Patrocínio RM, Alves AP. Rare hybrid odontogenic tumor in a 2-year-old child. J Craniofac Surg 2011; 22(2):554-8. doi: 10.1097/SCS.0b013e3182074616 [Crossref] [ Google Scholar]
  40. Rosa AC, Soares AB, Furuse C, Lima SR, de Araújo VC, Passador-Santos F. A combined epithelial odontogenic tumor? A 7-year follow-up case. Head Neck Pathol 2017; 11(4):519-24. doi: 10.1007/s12105-016-0767-9 [Crossref] [ Google Scholar]
  41. Miyake M, Nagahata S, Nishihara J, Ohbayashi Y. Combined adenomatoid odontogenic tumor and calcifying epithelial odontogenic tumor: report of case and ultrastructural study. J Oral Maxillofac Surg 1996; 54(6):788-93. doi: 10.1016/s0278-2391(96)90706-5 [Crossref] [ Google Scholar]
  42. Bhat KK, Amin R, Shetty P. Adenomatoid odontogenic tumour with calcifying epithelial odontogenic tumour component: a rare report of an intricate histomorphology. J Oral Maxillofac Pathol 2014; 5(3):24-7. [ Google Scholar]
  43. Phillips MD, Closmann JJ, Baus MR, Torske KR, Williams SB. Hybrid odontogenic tumor with features of ameloblastic fibro-odontoma, calcifying odontogenic cyst, and adenomatoid odontogenic tumor: a case report and review of the literature. J Oral Maxillofac Surg 2010; 68(2):470-4. doi: 10.1016/j.joms.2009.04.118 [Crossref] [ Google Scholar]
  44. Lin CC, Chen CH, Lin LM, Chen YK, Wright JM, Kessler HP. Calcifying odontogenic cyst with ameloblastic fibroma: report of three cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004; 98(4):451-60. doi: 10.1016/j.tripleo.2004.01.010 [Crossref] [ Google Scholar]
  45. Mahdavi N, Kardooni Khoozestani N, Hasheminasab M, Soltani N. Hybrid odontogenic tumor of calcifying odontogenic cyst and ameloblastic fibroma: a case report and review of literature. J Dent (Shiraz) 2020; 21(2):153-7. doi: 10.30476/dentjods.2019.77806 [Crossref] [ Google Scholar]
  46. Neuman AN, Montague L, Cohen D, Islam N, Bhattacharyya I. Report of two cases of combined odontogenic tumors: ameloblastoma with odontogenic keratocyst and ameloblastic fibroma with calcifying odontogenic cyst. Head Neck Pathol 2015; 9(3):417-20. doi: 10.1007/s12105-014-0601-1 [Crossref] [ Google Scholar]
  47. Yoon JH, Kim HJ, Yook JI, Cha IH, Ellis GL, Kim J. Hybrid odontogenic tumor of calcifying odontogenic cyst and ameloblastic fibroma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004; 98(1):80-4. doi: 10.1016/j.tripleo.2004.01.003 [Crossref] [ Google Scholar]
  48. Ravi SB, Prashanthi C, Karun V, Melkundi M, Nyamati S, Annapoorna HB. Collision lesion of mandible--coexistence of keratocystic odontogenic tumor with central giant cell granuloma: a rare case report. J Contemp Dent Pract 2013; 14(2):355-9. doi: 10.5005/jp-journals-10024-1327 [Crossref] [ Google Scholar]
  49. Yoon JH, Kim SG, Lee SH, Kim J. Simultaneous occurrence of an odontogenic keratocyst and giant cell granuloma-like lesion in the mandible. Int J Oral Maxillofac Surg 2004; 33(6):615-7. doi: 10.1016/j.ijom.2003.09.007 [Crossref] [ Google Scholar]
  50. Tippu SR, Rahman F, Sharma N, Srivastava S. Collision tumor of the palate: a rare case report. Contemp Clin Dent 2014; 5(1):102-5. doi: 10.4103/0976-237x.128682 [Crossref] [ Google Scholar]
  51. Yamazaki M, Maruyama S, Abé T, Babkair H, Fujita H, Takagi R. Hybrid ameloblastoma and adenomatoid odontogenic tumor: report of a case and review of hybrid variations in the literature. Oral Surg Oral Med Oral Pathol Oral Radiol 2014; 118(1):e12-8. doi: 10.1016/j.oooo.2013.08.032 [Crossref] [ Google Scholar]
  52. Rezvani G, Donoghue M, Reichart PA, Pazuhi N. Case presentation of concomitant and contiguous adenomatoid odontogenic tumor and focal cemento-ossifying dysplasia. Open Dent J 2015; 9:340-5. doi: 10.2174/1874210601509010340 [Crossref] [ Google Scholar]
  53. Li BB, Xie XY, Jia SN. Adenomatoid odontogenic tumor with fibro-osseous reaction in the surrounding tissue. J Craniofac Surg 2013; 24(1):e100-1. doi: 10.1097/SCS.0b013e3182799005 [Crossref] [ Google Scholar]
  54. Naidu A, Slater LJ, Hamao-Sakamoto A, Waters P, Kessler HP, Wright JM. Adenomatoid odontogenic tumor with peripheral cemento-osseous reactive proliferation: report of 2 cases and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol 2016; 122(3):e86-92. doi: 10.1016/j.oooo.2015.12.003 [Crossref] [ Google Scholar]
  55. Prakash AR, Reddy PS, Bavle RM. Concomitant occurrence of cemento-ossifying fibroma and adenomatoid odontogenic tumor with bilateral impacted permanent canines in the mandible. Indian J Dent Res 2012; 23(3):434-5. doi: 10.4103/0970-9290.102255 [Crossref] [ Google Scholar]
  56. Tosios KI, Gopalakrishnan R, Koutlas IG. So-called hybrid central odontogenic fibroma/central giant cell lesion of the jaws A report on seven additional cases, including an example in a patient with cherubism, and hypotheses on the pathogenesis. Head Neck Pathol 2008; 2(4):333-8. doi: 10.1007/s12105-008-0076-z [Crossref] [ Google Scholar]
  57. Younis RH, Scheper MA, Lindquist CC, Levy B. Hybrid central odontogenic fibroma with giant cell granuloma-like component: case report and review of literature. Head Neck Pathol 2008; 2(3):222-6. doi: 10.1007/s12105-008-0063-4 [Crossref] [ Google Scholar]
  58. Jois HS, Kumar KP, Kumar MS, Waghrey S. A mixed neoplasm of intraosseous hemangioma with an ameloblastoma: a case of collision tumor or a rare variant?. Clin Pract 2012; 2(1):e5. doi: 10.4081/cp.2012.e5 [Crossref] [ Google Scholar]
  59. Saxena A, Memauri B, Hasegawa W. Initial diagnosis of small lymphocytic lymphoma in parotidectomy for Warthin tumour, a rare collision tumour. J Clin Pathol 2005; 58(3):331-3. doi: 10.1136/jcp.2004.019760 [Crossref] [ Google Scholar]
  60. Ruíz-Godoy LM, Mosqueda-Taylor A, Suárez-Roa L, Poitevin A, Bandala-Sánchez E, Meneses-García A. Hybrid tumours of the salivary glands A report of two cases involving the palate and a review of the literature. Eur Arch Otorhinolaryngol 2003; 260(6):312-5. doi: 10.1007/s00405-002-0566-7 [Crossref] [ Google Scholar]
  61. Croitoru CM, Suarez PA, Luna MA. Hybrid carcinomas of salivary glands Report of 4 cases and review of the literature. Arch Pathol Lab Med 1999; 123(8):698-702. doi: 10.5858/1999-123-0698-hcosg [Crossref] [ Google Scholar]
  62. Woo JS, Kwon SY, Jung KY, Kim I. A hybrid carcinoma of epithelial-myoepithelial carcinoma and adenoid cystic carcinoma in maxillary sinus. J Korean Med Sci 2004; 19(3):462-5. doi: 10.3346/jkms.2004.19.3.462 [Crossref] [ Google Scholar]
  63. Hebbale MA, Halli RC, Kini YK, Kharkar VR, Metgud R. Adenoid cystic carcinoma associated with mucous retention cyst of the parotid gland. J Craniofac Surg 2011; 22(5):1937-9. doi: 10.1097/SCS.0b013e3182115184 [Crossref] [ Google Scholar]
  64. Eichhorn W, Precht C, Wehrmann M, Hickmann E, Eichhorn M, Zeuch J. First description of a hybrid tumor of the sublingual gland. Anticancer Res 2013; 33(10):4567-71. [ Google Scholar]
  65. Sabri A, Bawab I, Khalifeh I, Alam E. Hybrid tumor of the parotid gland: a case report and review of the literature. Case Rep Otolaryngol 2015; 2015:192453. doi: 10.1155/2015/192453 [Crossref] [ Google Scholar]
  66. Kainuma K, Oshima A, Suzuki H, Fukushima M, Shimojo H, Usami S. Hybrid carcinoma of the parotid gland: report of a case (epithelial-myoepithelial carcinoma and salivary duct carcinoma) and review of the literature. Acta Otolaryngol 2010; 130(1):185-9. doi: 10.3109/00016480902930458 [Crossref] [ Google Scholar]
  67. Gross BC, Carlson ML, Driscoll CL, Moore EJ. Collision tumor of the facial nerve: a synchronous seventh nerve schwannoma and neurofibroma. Otol Neurotol 2012; 33(8):1426-9. doi: 10.1097/MAO.0b013e31826a52aa [Crossref] [ Google Scholar]
  68. Lim YC, Kim WS, Choi EC. Collision metastasis of squamous carcinoma of the oral tongue and incidental thyroid papillary carcinoma to a single cervical lymph node. Int J Oral Maxillofac Surg 2008; 37(5):494-6. doi: 10.1016/j.ijom.2007.11.018 [Crossref] [ Google Scholar]
  69. Misawa K, Kawasaki H, Endo S, Mochizuki D, Morita K, Hashimoto Y. Primary combined small and squamous cell carcinoma of the hypopharynx: a case report. Mol Clin Oncol 2016; 4(5):709-14. doi: 10.3892/mco.2016.788 [Crossref] [ Google Scholar]
  70. Huang SF, Chuang WY, Cheng SD, Hsin LJ, Lee LY, Kao HK. A colliding maxillary sinus cancer of adenosquamous carcinoma and small cell neuroendocrine carcinoma--a case report with EGFR copy number analysis. World J Surg Oncol 2010; 8:92. doi: 10.1186/1477-7819-8-92 [Crossref] [ Google Scholar]
  71. Sahoo NK, Sharma R, Roy ID, Kulkarni V. Collision tumor of maxilla: a diagnostic dilemma. J Maxillofac Oral Surg 2015; 14(Suppl 1):370-3. doi: 10.1007/s12663-013-0603-7 [Crossref] [ Google Scholar]
  72. La Rosa S, Furlan D, Franzi F, Battaglia P, Frattini M, Zanellato E. Mixed exocrine-neuroendocrine carcinoma of the nasal cavity: clinico-pathologic and molecular study of a case and review of the literature. Head Neck Pathol 2013; 7(1):76-84. doi: 10.1007/s12105-012-0379-y [Crossref] [ Google Scholar]
  73. Kakarala K, Sadow PM, Emerick KS. Cervical lymph node collision tumor consisting of metastatic squamous cell carcinoma and B-cell lymphoma. Laryngoscope 2010; 120 Suppl 4:S156. doi: 10.1002/lary.21620 [Crossref] [ Google Scholar]
  74. Boyd AS, Rapini RP. Cutaneous collision tumors An analysis of 69 cases and review of the literature. Am J Dermatopathol 1994; 16(3):253-7. [ Google Scholar]
  75. Tan ST, Ghaznawie M, Heenan PJ, Dosan R. Basal cell carcinoma arises from interfollicular layer of epidermis. J Oncol 2018; 2018:3098940. doi: 10.1155/2018/3098940 [Crossref] [ Google Scholar]
  76. Irani S, Mohsenifar Z. Endocan, ET-1, and ETAR expression profiles in unicystic ameloblastoma, multicystic ameloblastoma, and ameloblastic carcinoma. Middle East J Cancer 2019; 10(3):167-74. doi: 10.30476/mejc.2019.78562 [Crossref] [ Google Scholar]
  77. Irani S, Alimohammadi S, Keyhan Shookoh S. The role of amelogenin protein in the development of human primary teeth. Iran J Neonatol 2023; 14(3):20-7. doi: 10.22038/ijn.2023.71062.2383 [Crossref] [ Google Scholar]
  78. Padma Priya S, Higuchi A, Abu Fanas S, Pooi Ling M, Kumari Neela V, Sunil PM. Odontogenic epithelial stem cells: hidden sources. Lab Invest 2015; 95(12):1344-52. doi: 10.1038/labinvest.2015.108 [Crossref] [ Google Scholar]
  79. Ide F, Obara K, Yamada H, Mishima K, Saito I, Horie N. Hamartomatous proliferations of odontogenic epithelium within the jaws: a potential histogenetic source of intraosseous epithelial odontogenic tumors. J Oral Pathol Med 2007; 36(4):229-35. doi: 10.1111/j.1600-0714.2007.00488.x [Crossref] [ Google Scholar]
  80. Irani S, Foroughi F. Histologic variants of calcifying odontogenic cyst: a study of 52 cases. J Contemp Dent Pract 2017; 18(8):688-94. doi: 10.5005/jp-journals-10024-2108 [Crossref] [ Google Scholar]
  81. Irani S, Alimohammadi S, Najafian T. Immunohistochemical localization of endothelin- 1 and endothelin a receptor in human primary tooth enamel organ. J Dent (Shiraz) 2023; 24(3):328-34. doi: 10.30476/dentjods.2022.95201.1845 [Crossref] [ Google Scholar]
  82. Manjunatha BS, Mahajan A, Mody BM, Shah V. Adenomatoid odontogenic tumor (AOT) arising from a dentigerous cyst: literature review and report of a case. J Maxillofac Oral Surg 2015; 14(2):393-7. doi: 10.1007/s12663-012-0369-3 [Crossref] [ Google Scholar]
  83. Kalburge JV, Latti B, Kalburge V, Kulkarni M. Neoplasms associated with dentigerous cyst: an insight into pathogenesis and clinicopathologic features. Arch Med Health Sci 2015; 3(2):309-13. doi: 10.4103/2321-4848.171936 [Crossref] [ Google Scholar]
  84. Indu S, Sood A, Mishra D. Hybrid odontogenic tumor masquerading as a salivary gland lesion: a diagnostic predicament. J Oral Maxillofac Pathol 2021; 25(Suppl 1):S32-6. doi: 10.4103/jomfp.JOMFP_51_20 [Crossref] [ Google Scholar]
  85. Jivan V, Altini M, Meer S, Mahomed F. Adenomatoid odontogenic tumor (AOT) originating in a unicystic ameloblastoma: a case report. Head Neck Pathol 2007; 1(2):146-9. doi: 10.1007/s12105-007-0005-6 [Crossref] [ Google Scholar]
  86. Sandhu SV, Narang RS, Jawanda M, Rai S. Adenomatoid odontogenic tumor associated with dentigerous cyst of the maxillary antrum: a rare entity. J Oral Maxillofac Pathol 2010; 14(1):24-8. doi: 10.4103/0973-029x.64308 [Crossref] [ Google Scholar]
  87. Channappa NK, Krishnapillai R, Rao JB. Cystic variant of calcifying epithelial odontogenic tumor. J Investig Clin Dent 2012; 3(2):152-6. doi: 10.1111/j.2041-1626.2011.00092.x [Crossref] [ Google Scholar]
  88. Imanimoghaddam M, Mortazavi S, Goudarzi F, Mohtasham N. A literature review of the rare coexistence of central giant cell granuloma with aneurysmal bone cyst: a case report. Iran J Otorhinolaryngol 2021; 33(118):319-25. doi: 10.22038/ijorl.2021.53844.2838 [Crossref] [ Google Scholar]
  89. Odell EW, Lombardi T, Barrett AW, Morgan PR, Speight PM. Hybrid central giant cell granuloma and central odontogenic fibroma-like lesions of the jaws. Histopathology 1997; 30(2):165-71. doi: 10.1046/j.1365-2559.1997.d01-585.x [Crossref] [ Google Scholar]
  90. Mosqueda Taylor A, Bermúdez Flores V, Díaz Franco MA. Combined central odontogenic fibroma and giant cell granuloma-like lesion of the mandible: report of a case and review of the literature. J Oral Maxillofac Surg 1999; 57(10):1258-62. doi: 10.1016/s0278-2391(99)90500-1 [Crossref] [ Google Scholar]
  91. Irani S, Dehghan A, Kalvandi Z. Correlation of clinical and histopathological features of salivary pleomorphic adenoma. J Dent (Shiraz) 2023; 24(4):404-9. doi: 10.30476/dentjods.2022.96307.1933 [Crossref] [ Google Scholar]
  92. Irani S, Jafari B. Expression of vimentin and CD44 in mucoepidermoid carcinoma: a role in tumor growth. Indian J Dent Res 2018; 29(3):333-40. doi: 10.4103/ijdr.IJDR_184_17 [Crossref] [ Google Scholar]
  93. Irani S, Bidari-Zerehpoush F. BRCA1/2 mutations in salivary pleomorphic adenoma and carcinoma-ex-pleomorphic adenoma. J Int Soc Prev Community Dent 2017; 7(Suppl 3):S155-62. doi: 10.4103/jispcd.JISPCD_184_17 [Crossref] [ Google Scholar]
  94. Irani S, Dehghan A. Expression of vascular endothelial-cadherin in mucoepidermoid carcinoma: role in cancer development. J Int Soc Prev Community Dent 2017; 7(6):301-7. doi: 10.4103/jispcd.JISPCD_323_17 [Crossref] [ Google Scholar]